NCT04202796

Catheter Ablation in Congenital Heart Disease: French National Prospective Registry

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 300 (estimated)
• Sponsor: Paris Cardiovascular Research Center (Inserm U970) · Other Government
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

Arrhythmias represent one of the main late complications in patients with congenital heart disease. Atrial arrhythmias are associated with a significant morbidity and are the first cause of urgent hospitalization, and sudden death from ventricular arrhythmias is a leading cause of death in this population. The exponential increase of the number of patients with congenital heart disease and the improvement of ablative technologies are associated with a significant increase of the number of catheter ablation procedures. Most of available studies are retrospective or include a limited number of patients. The aim of this study is to assess the efficacy of catheter ablation in patients with congenital heart disease through a national prospective registry. Secondary objectives are i) to identify factors associated with catheter ablation efficacy in different cardiac defects, ii) to describe complications associated with catheter ablation in this specific population, and iii) to assess the impact of catheter ablation on quality of life of patients with congenital heart disease.

Conditions

• Congenital Heart Disease
• Arrhythmia

Interventions

Type	Name	Description
PROCEDURE	Catheter ablation	Catheter ablation of arrhythmia

Timeline

• Start date: 2020-01-01
• Primary completion: 2021-12-31
• Completion: 2023-12-31
• First posted: 2019-12-18
• Last updated: 2021-03-09

Locations

1 site across 1 country: France